ErbenR.G., Silva-LimaB., ReischlI., SteinhoffG., TiedemannG., DalemansW., VosA., JanssenR.T.A., Le BlancK., van OschG.J.V.M., and LuytenF.P.White paper on how to go forward with cell-based advanced therapies in Europe. Tissue Eng Part A, 20, 2549, 2014.
2.
LoringJ.E., McDeveittT.C., PalecekS.P., SchafferD.V., ZandstraP.W., and NeremR.M.A global assessment of stem cell engineering. Tissue Eng Part A, 20, 2575, 2014.
3.
Keren PazT., and El HajA.J.Liability versus innovation—the legal case for regenerative medicine. Tissue Eng Part A, 20, 2555, 2014.
4.
NiemansburgS., TeraaM., HesamH., van DeldenJ., VerhaarM., and BredenoordA.L.Stem cell trials for vascular medicine: ethical rationale. Tissue Eng Part A, 20, 2567, 2014.
5.
ZoellerK.Science and the lay perspective: lay people's involvement in assessing tissue engineering issues. Tissue Eng Part A, 20, 2561, 2014.
